Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?
- 15 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (12) , 1567-1575
Abstract
The past decade has seen significant advances in understanding of the pathogenesis and progression of lung disease in cystic fibrosis (CF). Pulmonary inflammation, infection, and structural lung damage manifest very early in life and are prevalent among preschool children and infants, often in the absence of symptoms or signs. Early childhood represents a pivotal period amenable to intervention strategies that could delay or prevent the onset of lung damage and alter the longer-term clinical trajectory for individuals with CF. This review summarizes what we have learned about early lung disease in children with CF and discusses the implications for future clinical practice and research.Keywords
This publication has 82 references indexed in Scilit:
- WS2.2 What do parents experience and how do they cope with the AREST CF early surveillance program for infants and children with cystic fibrosis?Journal of Cystic Fibrosis, 2013
- Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?European Respiratory Journal, 2012
- Air Trapping on Chest CT Is Associated with Worse Ventilation Distribution in Infants with Cystic Fibrosis Diagnosed following Newborn ScreeningPLOS ONE, 2011
- Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic FibrosisClinical Infectious Diseases, 2011
- Bronchiectasis in Infants and Preschool Children Diagnosed with Cystic Fibrosis after Newborn ScreeningThe Journal of Pediatrics, 2009
- Recovery of Birth WeightzScore Within 2 Years of Diagnosis Is Positively Associated With Pulmonary Status at 6 Years of Age in Children With Cystic FibrosisPediatrics, 2009
- Cystic FibrosisNew England Journal of Medicine, 2005
- Early morphologic changes in the lungs of asymptomatic infants and young children with cystic fibrosisThe Journal of Pediatrics, 2004
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalitiesThe Journal of Pediatrics, 2001